Haemonetics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022
Net Income	97.31	167.68	117.56	115.4	43.38
Depreciation & Amortization	111.72	115.59	97.22	93.31	97.75
Stock-Based Compensation	33.83	29.64	28.33	25.58	24.36
Other Adjustments	74.02	-29.21	13.35	13.26	21.96
Change in Receivables	-14.88	6.96	-24.19	-24.42	-34.97
Changes in Inventories	47.36	-64.7	-60.06	30.75	24.31
Changes in Accounts Payable	-16.57	-19.21	44.58	39.82	7.64
Changes in Income Taxes Payable	-4.53	0.23	-0.98	1.69	2.87
Changes in Other Operating Activities	-35.03	-25.23	-34.05	-22.33	-15.02
Operating Cash Flow	293.22	181.73	181.75	273.06	172.26
Operating Cash Flow Growth	61.35%	-0.01%	-33.44%	58.51%	58.32%
Capital Expenditures	-32.78	-39.28	-38.13	-191.33	-96.51
Sale of Property, Plant & Equipment	1.38	23.25	1.81	1.61	2.02
Payments for Business Acquisitions	-60.18	-150.91	-243.85	-2.85	-2.5
Proceeds from Business Divestments	-	43.29	1.5	0.85	10.64
Other Investing Activities	-87.96	-38.26	-43.72	47.93	51.8
Investing Cash Flow	-179.55	-161.9	-322.39	-143.79	-86.35
Long-Term Debt Issued	300	950	110	330	-
Long-Term Debt Repaid	-306.25	-502.69	-72.25	-339.63	-17.5
Net Long-Term Debt Issued (Repaid)	-6.25	447.31	37.75	-9.63	-17.5
Issuance of Common Stock	7.89	8.33	7.21	7.02	6.55
Repurchase of Common Stock	-180	-235.24	-5.89	-75	-
Net Common Stock Issued (Repurchased)	-172.11	-226.91	1.33	-67.98	6.55
Other Financing Activities	-0.1	-111.58	-0.92	-22.76	-4.8
Financing Cash Flow	-178.46	108.82	38.16	-100.36	-15.75
Effect of Exchange Rate Changes on Cash and Cash Equivalents	3.46	-0.69	-3.19	-3.94	-2.98
Net Cash Flow	-61.32	127.96	-105.67	24.97	67.19
Free Cash Flow	260.44	142.45	143.63	81.73	75.75
Free Cash Flow Growth	82.83%	-0.82%	75.73%	7.89%	5.56%
FCF Margin	19.52%	10.47%	10.97%	6.99%	7.63%
Free Cash Flow Per Share	5.50	2.81	2.79	1.59	1.48
Levered Free Cash Flow	161.22	582.38	163.89	57.68	46.91
Unlevered Free Cash Flow	189.29	142.78	136.22	79.24	76.08

SEC Filings: 10-K · 10-Q